Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pharmexcil

India-UK FTA projected to boost Indian pharma exports by over 8% to $981 million in FY27: Pharmexcil

Indian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agreement will eliminate tariffs on most products. This pact is expected to enhance the competitiveness of Indian generic medicines in the British market. The agreement also aims to secure supply chains and…

The Economic Times · Jul 16

India-UK FTA: Pharma industry flags regulatory priorities ahead of July 15 rollout

Industry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will determine the pact’s long-term impact.

The Economic Times · Jul 10

Over 60% of pharma MSMEs yet to comply with updated manufacturing norms

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shortages, funding constraints, and rising compliance costs pose challenges for smaller drug makers within the SME ecosystem..

The Economic Times · Jun 3

From analysis to the latest developments in health,
read the most diverse news in one place.

Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbook

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

The Economic Times · Apr 30

Indian firms dumped Rs 1,000 crore of unapproved opioid pills into West Africa’s drug crisis

This article is the result of a collaboration with Netherlands-based open-source media outlet Bellingcat. Read Bellingcat’s editorially independent coverage here.

Newslaundry · Apr 17

Gambia unveils pre-shipment testing for Indian pharma

Gambia introduces pre-shipment inspection for Indian pharma following deaths linked to Indian cough syrup; Pharmexcil says all imported pharma must be inspected, tested for quality; India allowing export of cough syrup only after sample tested, CoA issued by govt lab.

The Hindu · Jul 12, 2023

Regulation for all medical devices from October 1, says DCGI

India is on course to introduce regulations governing all the medical devices in the country on October 1, Drugs Controller General of India Rajeev Singh Raghuvanshi said at iPhex 2023

The Hindu · Jul 5, 2023

Read news from The Economist, FT, and more,
with one subscription

Three-day international pharma expo to begin in Hyderabad on July 5

Over the years, the exhibition has emerged as a platform bringing together exporters from India, buyers from various countries as well as officials tasked with increasing trade and those from regulatory bodies.

The Hindu · Jun 20, 2023

Morning Digest | 233 people killed, over 900 injured in Odisha triple train crash; PM Modi announced ex-gratia of ₹2 lakh for next of kin of deceased, and more

The Hindu’s Morning Digest brings readers a select list of stories to start the day

The Hindu · Jun 3, 2023

Pharma exporters body suspends membership of Maiden Pharmaceuticals

Pharmexcil had sought details after WHO named the firm in a medical product alert

The Hindu · Oct 8, 2022

Gambia deaths | Pharma exporters body asks Maiden to share details

The incident has left a serious dent in the reputation of Indian pharma industry and exports, says Director-General

The Hindu · Oct 6, 2022

Pharma expo IPHEX to feature global regulators conclave

Serve as a platform for convergence, says Pharmexcil DG Ravi Udaya Bhaskar

The Hindu · Sep 12, 2022

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party

Maiden Pharmaceuticals

12 stories

Pharmexcil

12 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.